Calza, L; Danese, I; Colangeli, V; Vandi, G; Manfredi, R; Girometti, N; Borderi, M; Appolloni, L; Puggioli, C; Viale, P, Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study., «AIDS RESEARCH AND HUMAN RETROVIRUSES», 2014, 30, pp. 1162 - 1169 [articolo]
Calza L; Vanino E; Salvadori C; Manfredi R; Colangeli V; Cascavilla A; Di Bari MA; Motta R; Viale P, Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients., «HIV CLINICAL TRIALS», 2014, 15, pp. 1 - 13 [articolo]
Leonardo Calza;Filippo Trapani;Caterina Salvadori;Eleonora Magistrelli;Roberto Manfredi;Vincenzo Colangeli;Maria Assunta Di Bari;Marco Borderi;Pierluigi Viale, Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir, «SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES», 2013, 45, pp. 147 - 154 [articolo]
Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P., Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk., «AIDS RESEARCH AND HUMAN RETROVIRUSES», 2013, 2013, pp. 547 - 556 [articolo]
R. Manfredi; B. Piergentili; G. Marinacci; L. Calza, Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies, «INTERNATIONAL JOURNAL OF STD & AIDS», 2012, 23, pp. 35 - 38 [articolo]
R. Manfredi; L. Calza; V. Colangeli; N. Dentale; G. Verucchi, Kidney failure during HIV disease treated with tenofovir, multiple concurrent diseases and drug therapies, «REVIEWS IN HEALTH CARE», 2012, 3, pp. 83 - 112 [articolo]
S. Sabbatani; R. Manfredi; S. Fiorino, La peste di Giustiniano (prima parte), «LE INFEZIONI IN MEDICINA», 2012, 20, pp. 125 - 139 [articolo]
S. Sabbatani; R. Manfredi; C. Fulgaro, Long-term stabilized immunological-virological parameters of HIV infection in an AIDS presenter followed for 20 years, with irregular or no antiretroviral therapy, «INTERNATIONAL JOURNAL OF STD & AIDS», 2012, 23, pp. 46 - 47 [articolo]
L. Calza; R. Manfredi; F. Trapani; C. Salvadori; V. Colangeli; M. Borderi; G. Grossi; R. Motta; P. Viale., Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy., «SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES», 2012, 44, pp. 381 - 387 [articolo]
S. Sabbatani; R. Manfredi; P. Ortolani; F.F. Trapani; P. Viale, Myopericarditis during a primary Epstein-Barr virus infection in an otherwise young adult. An unusual and insidious complication. Case report and a 60-year literature review, «LE INFEZIONI IN MEDICINA», 2012, 20, pp. 75 - 81 [articolo]
Calza L; Manfredi R, Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection., «CURRENT HIV RESEARCH», 2012, 10, pp. 661 - 672 [articolo]
R. Manfredi; N. Dentale; L. Calza, Spontaneuous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis, «INTERNATIONAL JOURNAL OF STD & AIDS», 2012, 23, pp. 48 - 50 [articolo]
L. Calza; F. Trapani; M. Bartoletti; R. Manfredi; V. Colangeli; M. Borderi; G. Grossi; R. Motta; P. Viale, Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors., «HIV CLINICAL TRIALS», 2012, 13, pp. 153 - 161 [articolo]
S. Sabbatani; R. Manfredi; S. Fiorino, The Justinian plague (part two. The influence of the epidemic on the Islamic Empire evolution), «LE INFEZIONI IN MEDICINA», 2012, 20, pp. 217 - 232 [articolo]
Manfredi R, Unexpectedly slow clinical, bacteriological, and radiological response of pulmonary tuberculosis to standard pharmacological therapy. Which role for novel antimicrobial compounds with anti-mycobacterial activity?, in: Advances in Medicine and Biology, NEW YORK, Nova Science Publishers, Inc., 2012, pp. 233 - 246 [capitolo di libro]
